Meeder Asset Management Inc Enzo Biochem Inc Transaction History

Meeder Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$2.12 - $3.22 $7,475 - $11,353	-3,526 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.82 - $3.87 $4,233 - $9,001	2,326 Added 193.83%	3,526 $9,000
Q4 2019 Feb 13, 2020	BUY	$2.57 - $3.68 $1,508 - $2,160	587 Added 95.76%	1,200 $3,000
Q3 2019 Oct 17, 2019	SELL	$3.01 - $4.0 $3,452 - $4,588	-1,147 Reduced 65.17%	613 $2,000
Q2 2019 Aug 05, 2019	BUY	$2.79 - $4.31 $4,910 - $7,585	1,760 New	1,760 $6,000
Q1 2019 Apr 16, 2019	SELL	$2.54 - $4.02 $1,031 - $1,632	-406 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$2.46 - $4.2 $44 - $75	-18 Reduced 4.25%	406 $1,000
Q3 2018 Nov 02, 2018	BUY	$3.81 - $5.53 $1,615 - $2,344	424 New	424 $0
Q1 2018 May 03, 2018	SELL	$5.43 - $8.36 $30,131 - $46,389	-5,549 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$8.15 - $10.55 $43,243 - $55,978	5,306 Added 2183.54%	5,549 $45,000
Q3 2017 Oct 20, 2017	BUY	$10.45 - $11.44 $2,539 - $2,779	243	243 $3,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $34.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.